JDD Buzz Series | Concerns & Diagnoses Among Patients with Skin of Color
People with skin of color are projected to become the majority of the U.S. population by 2044. As the population diversifies, how can dermatology clinicians better understand the dermatologic concerns of people with darker skin tones? A study published in the April Journal of Drugs in Dermatology sheds light on the most common reasons why patients of color seek outpatient dermatologic care, and th …
People with skin of color are projected to become the majority of the U.S. population by 2044. As the population diversifies, how can dermatology clinicians better understand the dermatologic concerns of people with darker skin tones? A study published in the April Journal of Drugs in Dermatology sheds light on the most common reasons why patients of color seek outpatient dermatologic care, and th … Continue reading "JDD Buzz Series | Concerns & Diagnoses Among Patients with Skin of Color"
Sunscreen use varies among different racial groups despite its scientifically proven benefits. A cross-sectional, questionnaire-based study in the June issue of the Journal of Drugs in Dermatology aims to understand the needs and challenges people with skin of color face when choosing and using sunscreen.
I interviewed author Jared Jagdeo, MD, MS, associate professor of dermatology and director …
Topical corticosteroids have been a mainstay of frontline therapy for atopic dermatitis (AD) for more than half a century. Now therapeutic advances are challenging that standard of care. Nonsteroidal topicals -- topical JAK inhibitors, aryl hydrocarbon receptor agonists, and PDE-4 inhibitors -- are expanding pathways of addressing the signs and symptoms of AD.
An article in the March Journal …
When a patient reveals they went online for health information, it’s tempting for a clinician to inwardly groan. Fears of self-diagnosis or misinformation about diagnosed conditions can make clinicians concerned when patients seek medical information through online forums and social media. Yet these virtual communities are incredibly popular, most notably Reddit and its discussion forums.
A …
GLP-1 receptor agonists are an increasingly popular treatment for type 2 diabetes and obesity. Additionally, some dermatologists are finding success with treating psoriasis and hidradenitis suppurativa with GLP-1s independent of an impact on weight loss. As GLP-1 use becomes even more common in medicine, it’s important to understand side effects, including skin effects that could lead GLP-1 pati …